These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1289513)

  • 1. The antihypertensive effect of verapamil in patients with chronic renal failure.
    Rodicio JL; Alcazar JM; Ruilope LM
    J Hum Hypertens; 1992 Dec; 6 Suppl 2():S41-3. PubMed ID: 1289513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of light exercise on renal hemodynamics in patients with hypertension and chronic renal disease.
    Svarstad E; Myking O; Ofstad J; Iversen BM
    Scand J Urol Nephrol; 2002; 36(6):464-72. PubMed ID: 12623513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diet and chronic renal failure].
    Wauters JP
    Schweiz Med Wochenschr; 1983 Jul; 113(29):1022-5. PubMed ID: 6612282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antihypertensive therapy in experimental chronic renal failure.
    Wight JP; Bassett AH; Hutchesson A; Thurrell W; el Nahas AM
    Miner Electrolyte Metab; 1991; 17(6):362-8. PubMed ID: 1823385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Difficult therapy in patients with renal failure. What protects, what damages the kidneys?].
    Stiefelhagen P
    MMW Fortschr Med; 2005 Apr; 147(16):4-6. PubMed ID: 16392389
    [No Abstract]   [Full Text] [Related]  

  • 7. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
    Iino Y; Hayashi M; Kawamura T; Shiigai T; Tomino Y; Yamada K; Kitajima T; Ideura T; Koyama A; Sugisaki T; Suzuki H; Umemura S; Kawaguchi Y; Uchida S; Kuwahara M; Yamazaki T;
    Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between low-protein diet and hypertension control].
    Cianciaruso B
    G Ital Nefrol; 2008; 25 Suppl 42():S29-34. PubMed ID: 18828131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stockholm clinical study on progression of chronic renal failure--an interim report.
    Bergström J; Alvestrand A; Bucht H; Gutierrez A
    Kidney Int Suppl; 1989 Nov; 27():S110-4. PubMed ID: 2636644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do changes in dietary salt influence blood pressure of hypertensive patients pharmacologically controlled with verapamil? The Salt-Switching-Study (SSS).
    Redón J; Lozano JV; de la Figuera M; Rodriguez JC; Garrido J; Alés-Martínez JE; Alvarez-Cantalapiedra I; Velasco-Quintana J
    J Hum Hypertens; 1995 Feb; 9(2):143-7. PubMed ID: 7752177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [How to slow the progression of chronic renal insufficiency].
    Rossert J; Ronco P
    Rev Prat; 2001 Feb; 51(4):378-84. PubMed ID: 11355601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of renal lesions in dogs after 11/12 reduction of renal mass. Influences of dietary protein intake.
    Polzin DJ; Leininger JR; Osborne CA; Jeraj K
    Lab Invest; 1988 Feb; 58(2):172-83. PubMed ID: 3339859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteinuria in mild to moderate hypertension: results of the VA cooperative study of six antihypertensive agents and placebo. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
    Preston RA; Materson BJ; Reda DJ; Hamburger RJ; Williams DW; Smith MH
    Clin Nephrol; 1997 May; 47(5):310-5. PubMed ID: 9181278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of dietary protein/calorie intake on renal morphology and function in cats with 5/6 nephrectomy.
    Adams LG; Polzin DJ; Osborne CA; O'Brien TD; Hostetter TH
    Lab Invest; 1994 Mar; 70(3):347-57. PubMed ID: 8145529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertensive emergencies.
    Moore MA
    Am Fam Physician; 1980 Mar; 21(3):141-6. PubMed ID: 7355684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lifestyle modifications to prevent and control hypertension. 5. Recommendations on dietary salt. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Fodor JG; Whitmore B; Leenen F; Larochelle P
    CMAJ; 1999 May; 160(9 Suppl):S29-34. PubMed ID: 10333851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying and slowing progressive chronic renal failure.
    Curtis B; Barrett BJ; Levin A
    Can Fam Physician; 2001 Dec; 47():2512-8. PubMed ID: 11785282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J; Mladenović Lj
    Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.